Aclaris Therapeutics
ACRS
#8619
Rank
C$0.18 B
Marketcap
$1.73
Share price
-7.89%
Change (1 day)
7.11%
Change (1 year)

EPS for Aclaris Therapeutics (ACRS)

EPS in 2023 (TTM): -$2.09

According to Aclaris Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.19. In 2022 the company made an earnings per share (EPS) of -$1.88 an increase over its 2021 EPS that were of -$2.31.

EPS history for Aclaris Therapeutics from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.0911.07%
2022-$1.88-18.4%
2021-$2.3135.83%
2020-$1.70-69.31%
2019-$5.53-3.22%
2018-$5.7267.63%
2017-$3.416.64%
2016-$3.2066.73%
2015-$1.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.09 40.65%๐Ÿ‡บ๐Ÿ‡ธ USA